Wilms’ Tumour gene (WT1) as a potential MRD marker in AML David Grimwade Standardised leukaemia-specific RT-qPCR assays for

First Page		Document Content
CEBPA WT1 Transcription factors CD135 RUNX1		Wilms’ Tumour gene (WT1) as a potential MRD marker in AML David Grimwade Standardised leukaemia-specific RT-qPCR assays for Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 769,00 KB Share Document on Facebook